［1］Bode C,Zhao G,Steinhagen F,et al.CpG DNA as a vaccine adjuvqnt［J］.Expert Rev Vaccines,2011,10(4):499-511.
[2]Anne Doster,Saskia Ziegler,Foermer S,et al.Phosphorothioate-modified CpG oligodeoxynucleotides mimic autoantigens and reveal a potential role for Toll-like receptor 9 in receptor revision［J］.Immunology,2013,139(2):166-178.
[3]Pichinuk E,Benhar L,Jacobi O,et al.Antibody targeting of cell-bound MUC1 SEA domain kills tumor cells ［J］.Cancer Res,2012，72(13):3324-3336.
[4]Geary SM,Lemke CD,Lubaroff DM,et al.Tumor immunotherapy using adenovirus vaccines in combination with intratumoral doses of CpG ODN［J］.Cancer Immunol Immunother,2011,60(9):1309-1317.
[5]Hack K,Reilly L,Proby C,et al.Wnt5a inhibits the CpG oligodeoxynucleotide-triggered activation of human plasmacytoid dendritic cells［J］.Clinical and Experimental Dermatology,2012,37(5):557-561.
[6]Renata Ursu,Sophie Taillibert,Banissi C,et al.Immunotherapy with CpG-ODN in neoplastic meningitis:A phase I trial［J］.Cancer Science,2015,106(9):1212-1218.
[7]Jordan M,Waxman DJ.CpG-1826 immunotherapy potentiates chemotherapeutic and anti-tumor immune responses to metronomic cyclophosphamide in a preclinical glioma model［J］.Cancer Letters,2016,373(1):88-96.
[8]Schuman JT，Grinstead JS，Apostolopoulos V，et al．Structural and dynamic consequences of increasing repeats in a MUC1 peptide tumor antigen［J］．Biopolymers，2005，77(2)：107-120．
[9]Wang L，Chen H，Liu FH，et al.Monoclonal antibody targeting MUC1 and increasing sensitivity to docetaxel as a novel strategy in treating human epithelial ovarian cancer ［J］．Cancer Letters,2011,300(2):122-133.
[10]Hou Rui,Jiang Luo,Liu Dawo，et al.Expression of MUC1 in ovarian serous tumor and its clinical significance［J］.Modern Oncology,2012,20(6):1250-1253.
[11]Zhang P，Yi S，Li X，et al．Preparation of triple-negative breast cancer vaccine through electrofusion with day-3 dendritic cells ［J］．PLoS One，2014，9(7)：e102197．
[12]Schettini J,Kidiyoor A,Besmer DM,et al.Intratumoral delivery of CpG-conjugated anti-MUC1 antibody enhances NK cell anti-tumor activity［J］.Cancer Immunol Immunother,2012,61(11):2055-2065.
[13]Alteber Z,Azulay M,Cafri G,et al.Cryoimmunotherapy with local co-administration of ex vivo generated dendritic cells and CpG-ODN immune adjuvant,elicits a specific antitumor immunity［J］.Cancer Immunol Immunother,2014,63(4):369-380.
[14]Préville X,Rittner K,Fend L.Shaping the tumor microenvironment with Modified Vaccinia Virus Ankara and TLR9 ligand［J］.Oncoimmunology,2015,4(5)：e1003013.
[15]Wang Z,Hall MD,Rewers-Felkins KA,et al.Dendritic cells enhance the activity of human MUC1-stimulated mononuclear cells against breast cancer［J］.Oncoimmunology,2013,2(2):152-154.